GlassScriptPhysician profile
Tram L Luu
NPI 1427057744
$979.30
in general payments reported to CMS, 2019-2025
10 companies · $141 in 2025
The $141 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $28.38 · 2021: $17.95 · 2022: $65.82 · 2023: $362 · 2024: $196 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $194.55 | 2023-2025 | |
| Pfizer INC. | $185.69 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $172.25 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Kaleo, INC. | $132.51 | 2019-2024 | Auvi-Q |
| Cranial Technologies, INC | $79.68 | 2019-2023 | Doc Band |
| Sobi, INC | $78.31 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $57.55 | 2022-2024 | |
| Shire North American Group INC | $28.94 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $26.84 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $22.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tram Luu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.